About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.11.68874180438713.4754
Domestic EquitiesDr. Reddy's Laboratories Ltd.8.85044252731540.2244
Domestic EquitiesDivi's Laboratories Ltd.8.1307752472496.2929
Domestic EquitiesCipla Ltd.7.54172961148460.3401
Domestic EquitiesAurobindo Pharma Ltd.5.70703056281348.3549
Domestic EquitiesLupin Ltd.5.11171617422312.0169
Domestic EquitiesMankind Pharma Ltd3.8759921555236.5816
Domestic EquitiesAlkem Laboratories Ltd.3.8340465164234.0287
Domestic EquitiesBiocon Ltd.3.64235680217222.3237
Domestic EquitiesGland Pharma Ltd.3.2043947263195.5909
Domestic EquitiesZydus Lifesciences Ltd.2.97361871599181.5077
Domestic EquitiesSyngene International Ltd.2.49572133581152.3377
Domestic EquitiesAlembic Pharmaceuticals Ltd.1.72131074403105.0659
Domestic EquitiesThyrocare Technologies Ltd.1.624774795599.1714
Domestic EquitiesPfizer Ltd.1.540118097094.0049
Domestic EquitiesSagility India Ltd1.52752000000093.2400
Domestic EquitiesMetropolis Healthcare Ltd.1.444444187288.1667
Domestic EquitiesMedplus Health Services Ltd1.428693707487.1994
Domestic EquitiesShilpa Medicare Ltd.1.401696314985.5517
Domestic EquitiesWindlas Biotech Ltd.1.389785765184.8260
Domestic EquitiesGlenmark Pharmaceuticals Ltd.1.324537882280.8444
Domestic EquitiesMedi Assist Healthcare Services Ltd1.3236151667180.7931
Domestic EquitiesAnthem Biosciences Ltd1.3092105263679.9109
Domestic EquitiesFine Organic Industries Ltd.1.305215024379.6709
Domestic EquitiesAarti Drugs Ltd.1.2807154269078.1758
Domestic EquitiesYatharth Hospital & Trauma Care Services Pvt Ltd1.2258116192574.8222
Domestic EquitiesJ.B.Chemicals & Pharmaceuticals Ltd.1.159440000070.7720
Domestic EquitiesStar Health & Allied Insurance1.0678146586965.1799
Domestic EquitiesEmcure Pharmaceuticals Ltd.1.039245000063.4320
Domestic EquitiesAdvanced Enzyme Technologies Ltd.0.9518165668858.1000
Domestic EquitiesFDC Ltd.0.9406119768957.4112
Domestic EquitiesSanofi Consumer Healthcare India Ltd0.849710567651.8658
Domestic EquitiesAstrazeneca Pharma India Ltd.0.82805502150.5423
Domestic EquitiesProcter & Gamble Health Ltd.0.75357801245.9920
Domestic EquitiesSenores Pharmaceuticals Ltd0.723364088344.1504
Domestic EquitiesSun Pharma Advanced Research Co. Ltd0.6696271519040.8745
Total 95.8860 5852.8383
Cash & Cash Equivalents and Net AssetsTREPS3.6048 220.0350
Cash & Cash Equivalents and Net AssetsNet Current Assets0.3716 22.6793
Cash & Cash Equivalents and Net AssetsCash Margin - Derivatives0.1377 8.4052
Total 4.1140 251.1195
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.